Global Neuromyelitis Optica Drug Competitive Landscape Professional Research Report 2024

Research Summary

Neuromyelitis optica (NMO) is an autoimmune disorder characterized by inflammation and damage to the optic nerves and spinal cord. The primary treatment for NMO involves the use of immunosuppressive drugs to reduce the frequency and severity of relapses. One of the main drugs used in the treatment of NMO is rituximab. Rituximab is a monoclonal antibody that targets specific immune cells called B cells, which play a role in the inflammatory response in NMO. By depleting B cells, rituximab can help reduce the autoimmune attack on the nervous system and alleviate symptoms in NMO patients. Other immunosuppressive drugs such as azathioprine, mycophenolate mofetil, and corticosteroids may also be used to manage NMO and prevent relapses. Additionally, symptomatic treatment may be provided to address specific symptoms, such as pain management and rehabilitation therapies to improve function and quality of life in NMO patients. The choice of medication and treatment approach can vary depending on the individual's medical history, severity of symptoms, and response to treatment. Therefore, it is important for NMO patients to work closely with their healthcare providers to develop a personalized treatment plan.

According to DIResearch's in-depth investigation and research, the global Neuromyelitis Optica Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Neuromyelitis Optica Drug include Pfizer, Fresenius, Teva, Sandoz, Intas, Gyjtrs, NANG KUANG, Baxter, Tianjin Kingyork, CSL, Grifols, Octapharma, CBOP etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Neuromyelitis Optica Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromyelitis Optica Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neuromyelitis Optica Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromyelitis Optica Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Neuromyelitis Optica Drug Include:

Pfizer

Fresenius

Teva

Sandoz

Intas

Gyjtrs

NANG KUANG

Baxter

Tianjin Kingyork

CSL

Grifols

Octapharma

CBOP

Neuromyelitis Optica Drug Product Segment Include:

Glucocorticoids

Immunotherapies

Others

Neuromyelitis Optica Drug Product Application Include:

Acute Attack

Remission Prophylactic Treatment

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Neuromyelitis Optica Drug Industry PESTEL Analysis

Chapter 3: Global Neuromyelitis Optica Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Neuromyelitis Optica Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Neuromyelitis Optica Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Neuromyelitis Optica Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Neuromyelitis Optica Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Neuromyelitis Optica Drug Market Overview

1.1 Product Definition and Statistical Scope

1.2 Neuromyelitis Optica Drug Product by Type

1.2.1 Global Neuromyelitis Optica Drug Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Glucocorticoids

1.2.3 Immunotherapies

1.2.4 Others

1.3 Neuromyelitis Optica Drug Product by Application

1.3.1 Global Neuromyelitis Optica Drug Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Acute Attack

1.3.3 Remission Prophylactic Treatment

1.4 Global Neuromyelitis Optica Drug Market Revenue Analysis (2019-2030)

1.5 Neuromyelitis Optica Drug Market Development Status and Trends

1.5.1 Neuromyelitis Optica Drug Industry Development Status Analysis

1.5.2 Neuromyelitis Optica Drug Industry Development Trends Analysis

2 Neuromyelitis Optica Drug Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Neuromyelitis Optica Drug Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Neuromyelitis Optica Drug Market Analysis by Regions

4.1 Neuromyelitis Optica Drug Overall Market: 2023 VS 2024 VS 2030

4.2 Global Neuromyelitis Optica Drug Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Neuromyelitis Optica Drug Revenue and Market Share by Region (2019-2024)

4.2.2 Global Neuromyelitis Optica Drug Revenue Forecast by Region (2025-2030)

5 Global Neuromyelitis Optica Drug Market Size by Type and Application

5.1 Global Neuromyelitis Optica Drug Market Size by Type

5.2 Global Neuromyelitis Optica Drug Market Size by Application

6 North America

6.1 North America Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Neuromyelitis Optica Drug Market Size by Type

6.4 North America Neuromyelitis Optica Drug Market Size by Application

6.5 North America Neuromyelitis Optica Drug Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Neuromyelitis Optica Drug Market Size by Type

7.4 Europe Neuromyelitis Optica Drug Market Size by Application

7.5 Europe Neuromyelitis Optica Drug Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Neuromyelitis Optica Drug Market Size by Type

8.4 China Neuromyelitis Optica Drug Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Neuromyelitis Optica Drug Market Size by Type

9.4 APAC (excl. China) Neuromyelitis Optica Drug Market Size by Application

9.5 APAC (excl. China) Neuromyelitis Optica Drug Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Neuromyelitis Optica Drug Market Size by Type

10.4 Latin America Neuromyelitis Optica Drug Market Size by Application

10.5 Latin America Neuromyelitis Optica Drug Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Neuromyelitis Optica Drug Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Neuromyelitis Optica Drug Market Size by Type

11.4 Middle East & Africa Neuromyelitis Optica Drug Market Size by Application

11.5 Middle East & Africa Neuromyelitis Optica Drug Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Neuromyelitis Optica Drug Market Revenue by Key Manufacturers (2020-2024)

12.2 Neuromyelitis Optica Drug Competitive Landscape Analysis and Market Dynamic

12.2.1 Neuromyelitis Optica Drug Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Pfizer

13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Pfizer Neuromyelitis Optica Drug Product Portfolio

13.1.3 Pfizer Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Fresenius

13.2.1 Fresenius Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Fresenius Neuromyelitis Optica Drug Product Portfolio

13.2.3 Fresenius Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Teva

13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Teva Neuromyelitis Optica Drug Product Portfolio

13.3.3 Teva Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Sandoz

13.4.1 Sandoz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sandoz Neuromyelitis Optica Drug Product Portfolio

13.4.3 Sandoz Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Intas

13.5.1 Intas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Intas Neuromyelitis Optica Drug Product Portfolio

13.5.3 Intas Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Gyjtrs

13.6.1 Gyjtrs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Gyjtrs Neuromyelitis Optica Drug Product Portfolio

13.6.3 Gyjtrs Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 NANG KUANG

13.7.1 NANG KUANG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 NANG KUANG Neuromyelitis Optica Drug Product Portfolio

13.7.3 NANG KUANG Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Baxter

13.8.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Baxter Neuromyelitis Optica Drug Product Portfolio

13.8.3 Baxter Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Tianjin Kingyork

13.9.1 Tianjin Kingyork Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Tianjin Kingyork Neuromyelitis Optica Drug Product Portfolio

13.9.3 Tianjin Kingyork Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 CSL

13.10.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 CSL Neuromyelitis Optica Drug Product Portfolio

13.10.3 CSL Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Grifols

13.11.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Grifols Neuromyelitis Optica Drug Product Portfolio

13.11.3 Grifols Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Octapharma

13.12.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Octapharma Neuromyelitis Optica Drug Product Portfolio

13.12.3 Octapharma Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 CBOP

13.13.1 CBOP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 CBOP Neuromyelitis Optica Drug Product Portfolio

13.13.3 CBOP Neuromyelitis Optica Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Neuromyelitis Optica Drug Industry Chain Analysis

14.2 Neuromyelitis Optica Drug Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Neuromyelitis Optica Drug Typical Downstream Customers

14.4 Neuromyelitis Optica Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support